Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 264.20
+7.90 (3.08%)
At close: Mar 13, 2026
Evogene Market Cap
Evogene has a market cap or net worth of 23.03 million as of March 13, 2026. Its market cap has decreased by -33.78% in one year.
Market Cap
23.03M
Enterprise Value
27.17M
Revenue
12.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
264.20
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 23.03M, a decrease of -79.64%. That is a compound annual growth rate of -8.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 23.03M | -12.09% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 499.87M |
| Geffen Residence & Renewal | 267.57M |
| Matricelf | 137.80M |
| Clal Biotechnology Industries | 45.33M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 29.72M |
| XTL Biopharmaceuticals | 19.87M |
| Purple Biotech | 18.58M |